乙醯化作用對SIK2活性的調控

Regulation of SIK2 Activity by Acetylation

孫惠鈺(Huei-Yu Sun)

指導教授 ： 呂勝春

國立臺灣大學/醫學院/分子醫學研究所/碩士(2007年)

https://doi.org/10.6342/NTU.2007.02154

摘要

第二型鹽誘導激酶（SIK2）為一種絲胺酸/蘇胺酸蛋白質激酶（Serine/threonine protein kinase），並屬於單磷酸腺苷蛋白質激酶（AMPK）族系的其中一個成員。過去的研究顯示，此蛋白質在成熟的脂肪細胞中大量表現並且在脂肪細胞分化過程中具有調控早期胰島素傳導的功能。迄今，除了IRS-1和TOC2外，對於SIK2其他生理上的受質仍未非常明暸。第一型胰島素受器受質（IRS-1）在脂肪組織的胰島素傳導中扮演重要的功能，並且被認為在第794位置的絲胺酸上會被SIK2磷酸化。而在CREB傳導途徑中具有調控功能的TORC2，則在第171位置的絲胺酸會被磷酸化。
在本研究中，我們發現了p97/VCP，一種參與在多樣細胞活動的三磷酸腺苷水解酶（AAA-ATPase），和SIK2在物理上和功能上具有交互作用。透過免疫螢光染色和蔗糖濃度梯度分層生化實驗，SIK2和p97/VCP被證明共同分佈在內質網膜（ER membrane）上。並且SIK2和p97/VCP的交互作用可調控p97/VCP所調解的內質網相關之蛋白質降解（ERAD）。座落於SIK2三磷酸腺苷嵌合區位（ATP-binding domain）上第53位置的賴胺酸（K53）可被進行乙醯化作用（Acetylation）。在我們之前的研究中指出K53的乙醯化作用可抑制SIK2的激酶活性，而此激酶活性對於由p97/VCP所調解的ERAD是需要的。本研究更進一步證明了以股氨酸取代第53位置賴胺酸的乙醯化擬態突變型（K53Q）會降低其激酶活性並導致ERAD受質CD3δ的累積增加。另外，我們還找到SIK2 K53的乙醯化作用和去乙醯化作用（Deacetylation）是由p300/CBP和HDAC6所負責調控的。綜合上述，我們的研究結果顯示SIK2的乙醯化作用減弱了其激酶活性並且進而抑制ERAD受質的降解。

關鍵字

SIK2 ； p97/VCP ； 乙醯化作用 ； p300/CBP ； HDAC6 ； ERAD

並列摘要

Salt-inducible kinase 2 (SIK2), a serine/threonine protein kinase, belongs to members of the AMP-activated protein kinase (AMPK) family. It is highly expressed in mature adipocytes and regulates the early phase of insulin-signaling during adipocyte differentiation. So far, the physiological substrates of SIK2 are not well-understood, except for IRS-1 and TORC2. Insulin receptor substrate-1 (IRS-1), which is reported to play important roles in the insulin-signaling in the adipose tissue, is thought to be a potential endogenous substrate of SIK2 at serine 794, whereas TOR2, participating in the regulation of CREB signaling, is phosphorylated at serine 171.
In the present study, we have identified that p97/VCP, an AAA-ATPase involved in a variety of cellular processes, interacts with SIK2 physically and functionally. Moreover, SIK2 and p97/VCP are co-localized to the ER membrane. The interaction between SIK2 and p97/VCP modulates p97/VCP-dependent ER-associated degradation (ERAD). Lysine 53, a site located in the kinase ATP-binding domain of SIK2, is found to be acetylated. We have previously described that lysine 53 acetylation results in the inhibition of the kinase activity of SIK2. The acetylation mimetic mutant K53Q showed accumulation of the ERAD substrate CD3δ. We further identified that p300 /CBP and HDAC6 are responsible for the acetylation and deacetylation of lysine 53 of SIK2. In conclusion, our results demonstrate that acetylation of SIK2 negatively regulates its kinase activity, thus attenuates the degradation of the ERAD substrates.

並列關鍵字

SIK2 ； p97/VCP ； Acetylation ； p300/CBP ； HDAC6 ； ERAD

參考文獻

Al-Hakim, A.K., Goransson, O., Deak, M., Toth, R., Campbell, D.G., Morrice, N.A., Prescott, A.R., and Alessi, D.R. (2005). 14-3-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK. Journal of cell science 118, 5661-5673.

Batta, K., Das, C., Gadad, S., Shandilya, J., and Kundu, T.K. (2007). Reversible acetylation of non histone proteins: role in cellular function and disease. Sub-cellular biochemistry 41, 193-212.

Bouras, T., Fu, M., Sauve, A.A., Wang, F., Quong, A.A., Perkins, N.D., Hay, R.T., Gu, W., and Pestell, R.G. (2005). SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. The Journal of biological chemistry 280, 10264-10276.

Boyes, J., Byfield, P., Nakatani, Y., and Ogryzko, V. (1998). Regulation of activity of the transcription factor GATA-1 by acetylation. Nature 396, 594-598.

Braun, S., Matuschewski, K., Rape, M., Thoms, S., and Jentsch, S. (2002). Role of the ubiquitin-selective CDC48(UFD1/NPL4 )chaperone (segregase) in ERAD of OLE1 and other substrates. The EMBO journal 21, 615-621.